 NovaBay Pharmaceuticals, Inc. NYSE American: NBY, a biopharmaceutical company focusing on commercializing Avenova for the domestic eye care market, announces that it will report 2019 fourth quarter and full year financial results after market close on Thursday, March 26, 2020 and will hold an investment community conference call that day. 